We are working with partners to enable early medical intervention for longer, healthier lives for humans and animals.
Attomarker Ltd is offering an Advanced Subscription Agreement funding round to support product development, regulatory and roll out.
A full set of documents and an investor webinar is available.
We are keen to hear from potential investors, individual or institutional, who would like to be kept informed of investment rounds and opportunities as they arise.
